|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|
|
|---|
| INTRODUCTION |
|
|
|---|
In Latin America, VL is still a disease of childhood with 60% of the cases occurring in children less than 10 years of age, an age group that has shown several other morbidities such as diarrhea. Diarrheal disease affects growth and development and is frequently associated with poor environmental health conditions and hygiene. These affects lead to more malnutrition,9–11 conditions frequently found in leishmanial-endemic areas, especially in northeastern Brazil where the disease-endemic area has reached peri-urban locations. Brazil has undergone important socioeconomic changes since rampant inflation was controlled in 1994. As a result of inflation control and several protective measures for lower income families, better redistribution of income and a decrease in malnutrition prevalence have occurred. This changing pattern in the economy occurred in parallel with the shift of the Brazilian population to more urban areas and the periurbanization of VL.
Breastfeeding has been shown worldwide to protect infants against diarrheal and respiratory infections,12–14 resulting in an improved nutritional status. Its protective role is long lasting and independent of socioeconomic conditions, number of residents in the family, and educational level of the parents.12 Birth weight is an indicator of intrauterine development,15 and several studies have consistently demonstrated its association with growth, development, morbidity, and mortality.16–18 Micronutrient status is also an important variable associated with infections.
Micronutrient deficiency co-exists with malnutrition in a complex cycle, especially in vulnerable populations within developing countries, such as pre-school children.19,20 Vitamin A has been considered the anti-infective vitamin since the 1920s.21 Studies have consistently demonstrated its effect in reducing child mortality caused by measles, pneumonia, diarrhea and also its effect in improving the prognosis in children with malaria.21–25 Animal models have shown that vitamin A deficiency is associated with a switch from a Th2 immune response, which is important for resolution of non-invasive infections, to a Th1 response, which is crucial for resolution of intracellular infections, such as those with L. chagasi.26–28
Expression of the interferon gamma (IFN-
) gene is down-regulated by retinoic acid, the active form of retinol in cells. A murine model has shown that vitamin A deficiency stimulated the production of Th1 cytokines IFN-
and interleukin-12 (IL-12), but not of IL-4 and IL-10, which are associated with a type 2 response. In the same study, vitamin A supplementation increased production of IL-4, IL-5, and IL-10 and decreased production of IFN-
.26 Supplementation of the diet with vitamin A either as a prophylactic or therapeutic measure promoted multiplication of L. donovani.29 However, a recent study conducted in a Bangladesh population showed low serum retinol concentrations in human VL cases.
Published data in human and animal models of Leishmania spp. infection linking the role of vitamin A in the outcome of Leishmania spp. infections are controversial, and few studies have focused on nutritional variables associated with the outcome of L. chagasi infection. We believe that the response to Leishmania spp. infection is dependent on individual and environmental factors that persist throughout years, including exposure to infection and nutritional status. In this study, we investigated nutritional status, breastfeeding history, birth weight, and vitamin A status with respect to the outcome of L. chagasi infection.
| MATERIALS AND METHODS |
|
|
|---|
Study groups and inclusion and exclusion criteria. Ongoing VL cases were enrolled after VL diagnosis at the Pediatrics Hospital in Natal, Brazil, and patients who recovered from VL and their relatives were chosen from an open cohort from a L. chagasi-endemic area, as described.30 In the cohort study, VL patients and their relatives were recruited with the objective to study the genetic determinants of L. chagasi infection. For this study, 149 children were enrolled and divided into four groups: 1) children with active VL (n = 20), 2) children with a previous history of VL (n = 33), 3) children with a positive delayed-type hypersensitivity (DTH) response to Leishmania spp. antigens (n = 40), and 4) children with no apparent signs of L. chagasi infection, but residing in the area that has VL and having a relative with VL (n = 56). Patients with active VL were enrolled in the hospital during treatment. Other groups were enrolled at their households during a follow-up of a patient who recovered from VL.
The four groups were analyzed according to their outcome of Leishmania spp. infection. Because all children had an apparently equal chance of exposure to Leishmania spp., in addition to having similar socioeconomic status, the nutrition variables were retrospectively analyzed and considered the outcome of Leishmania spp. infection. The active VL group contained symptomatic persons undergoing specific treatment. The recovered VL group contained persons whose disease was resolved after successful treatment. Children with asymptomatic (DTH+) infection were persons who showed a protective response to Leishmania spp. infection. The no L. chagasi infection group (DTH-) contained children with no apparent signs of L. chagasi infection, but who resided in a disease-endemic area and had a sibling with either VL or DTH+.
Inclusion criteria for each group were as follows. Active VL was defined as current, symptomatic VL with a diagnosis of VL confirmed by positive results for bone marrow aspirates or positive results for antibody to rK39 antigen. Symptomatic disease was defined as a history of intermittent fever for more than three weeks, hepatomegaly and/or splenomegaly, hyper-gammaglobulinemia, and low hematocrit and hemoglobin levels. Previous history of VL was defined as recovery from VL a year post-treatment. Asymptomatic infection with L. chagasi was defined as a positive DTH result in the Montenegro skin test (
5 mm in duration at 48–72 hours) and antibody against soluble L. chagasi antigen (SLA) with no history of disease. No apparent signs of L. chagasi infection was defined as a negative DTH result in the Montenegro skin test and a negative result for antibody against SLA.
The exclusion criteria for all groups were children with fever, with the exception of the confirmed VL cases, children who were physically or mentally impaired, children with chronic diseases, children more than 14 years of age, and children who refused to participate and/or parents/guardians did not allow their children to participate in the study.
Sample collection. A sample of approximately 10 mL of venous blood was collected from each child. Antibodies to SLA and rK39, and levels of vitamin A, albumin, total protein, globulins, C-reactive protein, and alpha-1-acid glycoprotein were determined. Blood samples were protected from light exposure.
Identification of Leishmania spp. infection. Two enzyme-linked immunosorbent assays (ELISAs) using SLA and rK39 protein as source of antigens were used, as described.31 Briefly, wells of ELISA plates (Costar; Corning Inc., Corning, NY) were coated with 200 ng of L. chagasi promastigote antigen or 50 ng of rK39. Each serum sample was assayed in triplicate. Each plate included negative control sera from unexposed Brazilians and positive control sera from patients with documented VL. The absorbance at 405 nm was determined using a Titertek Multiskan plate reader (ICN Biomedical Inc., Costa Mesa, CA). The cut-off was the mean absorbance plus three standard deviation values of negative control sera. The cut-off values were 0.117 for antibodies to SLA and 0.093 for antibodies to rK39.
The Montenegro skin test was performed using 25 µg of Leishmania spp. proteins (Centro de Produção e Pesquisa de Imunobiológicos, Secretaria de Saúde, Paraná, Brazil) injected intradermally. Skin tests were read after 48–72 hours by measuring in two perpendicular directions using the ball-point pen method.32 A positive test result was defined if the mean of the two induration measurements was greater than 5 mm.33
Modified relative dose response test and serum retinol identification.
The modified relative dose response test (MRDR) was used to indirectly determine liver storage of vitamin A because serum retinol concentrations decrease with acute-phase infections.34–36 One dose of 3,4-didehydroretinyl acetate (3,4-DHRA), a vitamin A analog not produced in humans, was given to each child dissolved in corn oil. A retinol-free snack containing approximately 10 grams of fat was given after 3,4-DHRA was administered to improve its absorption. The test uses the ratio of 3,4-didehydroretinol (3,4-DHR) to retinol and when liver concentrations of retinol are low, more 3,4-DHR binds to retinol-binding protein and circulates in the blood.37 Standard doses were given according to age as follows: 5.3 µmol to children less than 6 years of age, 7.0 µmol to children 6–12 years of age, and 8.8 µmol to children more than 12 years of age.38 A MRDR value
0.060 was considered indicative of inadequate vitamin A status, one between 0.030 and 0.060 was uncertain, and a value
0.030 showed adequate vitamin A status.37 Serum retinol was considered low or possibly responsive to greater intake when < 30 µg/dL, inadequate when < 20 µg/dL, and deficient when < 10 µg/dL.39,40
Acute-phase proteins. C-reactive protein and alpha 1-acid glycoprotein were measured by immune turbidimetry.41 C-reactive protein was used to assess the presence of acute inflammation caused by L. chagasi in children with active VL or other infections in children from leishmaniasis-endemic areas. The alpha-1-acid glycoprotein was used to measure convalescence from infection because it can decrease retinol levels by 11%.42
Anthropometric measures and nutritional assessment. Weight and height measurements were taken from each child using calibrated methods and standardized techniques by a trained researcher. A digital weighing scale with a precision of 100 grams and a capacity of 150 kg capacity (Plenna, São Paulo, Brazil) was used to measure weight. The supine height for children less than two years of age old and standing height for children more than two 2 years of age old was measured with a portable anthropometric rod (Invicta Education, Leicester, United Kingdom) with an accuracy of 0.1 cm. Once weight could be positively affected by hepatosplenomegaly in active VL, we used mid-upper arm circumference (MUAC)–for-height as a measure of ponderal loss in the studied children. The MUAC was measured using a rod with an accuracy of 0.1 cm in the middle of the arm. Weight-for-age, height-for-age, weight-for-height, MUAC-for-height, and body mass index z-scores were calculated using Centers for Disease Control and Prevention (Atlanta, GA) 2000 references from Epi-Info software, version 3.4.1 (Centers for Disease Control and Prevention).
History of breastfeeding was collected from interviewing the childrens mothers or guardians. In Brazil, birth weight is recorded in childrens vaccine cards provided by the Ministry of Health at time of birth. This record was used to assess nutritional status at birth.
Statistical analysis. Sample size calculations were performed using serum retinol concentration as parameter from a pilot study of 15 children with active VL and 60 children residing in the area endemic for VL (20 with asymptomatic infection, 20 with history of VL, and 20 with no infection). The sample size to detect a significant difference between the groups was 20 for each group using a power of 90% and a two-sided significance level of 5%.
To detect differences between groups by sex, and vitamin A deficiency, the chi-square test was used. The Kolmogorov-Smirnov test was used to test the normality of continuous variables. Levenes test was used to determine the variance and linearity of continuous variables. Because the variables age, birth weight, breastfeeding time, exclusive breastfeeding time, retinol, MRDR, C-reactive protein, alpha-1-acid glyco-protein, albumin, and globulin had normal distribution and were linear, one-way analysis of variance (ANOVA) was used to test for significant variables. Tukeys post hoc test was used in the variables that were significant by ANOVA to compare means between each group. For Tukeys post hoc test, only P values < 0.05 are shown.
To evaluate the means for birth weight and total and exclusive breastfeeding time, children with active VL and a history of VL were considered as the same group because these parameters are not associated with acute-phase responses.
Pearson linear correlation was used to test the correlation between antibodies to SLA, body mass index, MUAC-for-height, serum vitamin A, and MRDR. Two multivariable logistic regression models were used to assess nutritional and biochemical factors associated with VL and asymptomatic infection, respectively. In the first model, the risk for the outcome VL is assessed, and children with VL are compared with other healthy groups. In the second model, where factors associated with the risk for an asymptomatic infection are assessed, children with asymptomatic infection are compared with children with active VL and a history of VL. In these models, values for β ± SD are presented to show the direction of the relationship between the variable and the outcome analyzed (whether positive or negative). The odds ratios with 95% confidence intervals are shown to assess for the risk found between a variable and the outcome analyzed in the model.
Statistical analysis was performed using the Statistical Package for Social Sciences version 11.5 (SPSS Inc., Chicago, IL). P values
0.05 were considered significant.
| RESULTS |
|
|
|---|
|
|
Data for breastfeeding history was available for 122 children. Birth weight was available and collated from vaccine cards for 87 children. Nutritional history of breastfeeding, exclusive breastfeeding, and birth weight were not different between groups, although there was a trend for children with VL to have a lower breastfeeding time (Table 3
).
|
|
Statistical analysis was performed to exclude children with high C-reactive protein (> 5 mg/dL) and/or high alpha-1-acid glycoprotein (> 100 mg/dL) levels within the healthy groups (four in the group with a history of VL, two in the group with asymptomatic infections, and eight in the group with no L. chagasi infections). The mean serum retinol level and result of the MRDR test did not change after this analysis for any of the groups, and significance between groups remained the same.
The prevalence of low serum retinol (< 30 µg/dL) levels was high in all groups (Table 5
), especially in children with active VL; 63% had low retinol levels, compared with 43.8% in children who recovered from VL, 46% in the asymptomatic infection group, and 50% in the children with no apparent signs of L. chagasi infection (P = 0.001, by chi-square test). Prevalence of vitamin A inadequate status measured by an MRDR test value
0.060 did not differ between groups, although 15% of children with active VL showed inadequate vitamin A status (Table 5
).
|
|
|
| DISCUSSION |
|
|
|---|
In this study, the presence of antibodies to Leishmania spp. was correlated with lower anthropometric indexes and worse vitamin A status, as indicated by a higher MRDR test result. However, we were not able to determine whether the low anthropometric measures seen in the VL group were caused by infection per se or were a contributing factor. These questions could be better answered by a prospective cohort study of children exposed to Leishmania spp. infection. However, VL occurs focally in a large geographic area of Rio Grande do Norte in Brazil, and the sample size of children needed to be followed to reach significance would be large and difficult to obtain. This is a limitation of this type of study. However, because a shorter history of breastfeeding and lower birth weight are indicative of a more tenuous prior nutritional status and a greater chance of being in the VL group, we believe that malnutrition precedes L. chagasi infection in this group and might contribute to the outcome of this infection.
Children who recovered from VL continue to have lower levels of vitamin A, even after a year of treatment, when inflammation has disappeared, which was shown by average C-reactive protein and alpha-1-acid glycoprotein concentrations. Although the serum retinol and the MRDR test results did not differ between the group with a history of VL and the healthy groups, they also did not differ from the group with active VL. This shows that these children may have a trend to have a worse vitamin A status than their counterparts. The diminished vitamin A status may have preceded active VL, as observed in a recent prospective study conducted in Bangladesh.47 These results reinforce the hypothesis that malnutrition precedes infection.
Several explanations may be offered for why vitamin A levels are reduced during VL. The results obtained in this study raise a number of questions related to the role of vitamin A in infection. One possibility is that a pre-existing immune abnormality predisposes a person to diminished vitamin A status and VL. A second possibility is that children with VL may have reduced vitamin A intake than their healthy relatives. Both of these factors may be active. Genetic regulators of serum retinol levels are still unknown. A case study showed a low level of retinol caused by a mutation in the retinol binding protein gene.48 Low plasma retinol binding protein concentrations were found in persons with a mutation in transthyretin, which complexes with retinol binding protein in the circulation at position 84 of the molecule.49 A potential mutation in STRA-6, the retinol binding protein receptor, which causes Matthew-Wood syndrome, could potentially be of importance in regulating vitamin A function.50,51 Thus, we cannot exclude the possibility of a gene-induced impairment of serum retinol levels in the children with VL. Further studies in the area are needed to corroborate this hypothesis.
In the present study, we compared children with VL with their relatives or with a population in similar socioeconomic conditions to control for the diet offered to the children. Red meat consumption was associated with protection from developing VL.47 In addition, a study conducted in mice fed with a hypocaloric, low-protein, zinc and iron diet showed more visceralization of L. donovani in these mice than in the control group. The investigators proposed that Leishmania spp. visceralization was probably caused by a lymph node barrier dysfunction, increased prostaglandin E2 production, decreased IL-10 production, and inducible nitric oxide synthase production.6 These studies indicate that food intake is possibly a regulator of the immune response to Leishmania spp. infection.
Acute infection and inflammation diminish serum retinol levels, probably because of increased excretion of retinol-binding protein and retinol.35,52 In contrast, the MRDR test result is not altered by acute abnormalities because a decrease in retinol-binding protein levels would equally affect both 3,4-DHR and retinol.53,54 Furthermore, children with a history of disease have decreased vitamin A levels. Thus, we can not attribute the decrease in vitamin A status exclusively to losses caused by acute infection, but to some other factor, including immunogenetics. Surprisingly, there was a high prevalence of vitamin A deficiency in the healthy group, in spite of the vitamin A supplementation and overall improvement in diet.55
Higher albumin concentrations were associated with protection from disease and the increased likelihood of self-resolving infection, although the 95% confidence intervals in both cases were very wide. Another risk factor that was associated with higher risk of VL is age, and the results of our study are consistent with the epidemiologic findings of lower age in children who develop the disease and higher age as a factor that increases the likelihood of having an asymptomatic infection.30,56
The results in this study emphasize the importance of current and previous nutritional status in the outcome of Leishmania spp. infection. Immunogenetic factors are implicated in the outcome of Leishmania spp. infection.3,5 Simple nutritional measures that might protect against development of disease, such as micronutrients provision from diet, are extremely important because they are modifiable factors that can be addressed in populations exposed to pathogens such as Leishmania spp.47 Our data support the notion that by looking at these measures and other nutritional factors such as breastfeeding time and birth weight, which reflects intrauterine and maternal nutrition, may also be important in the outcome of Leishmania spp. infection and should be addressed in high-risk areas. Finally, vitamin A supplementation and breastfeeding are measures that can be implemented.
Received March 25, 2008. Accepted for publication May 30, 2008.
Acknowledgments: We thank Manoel Fernandes (Fundação Nacional de Saúde) for assistance during field work studies, Dr. Goreti Macedo (Biochemistry Engineering Department, Federal University of Rio Grande do Norte) for assistance and advice regarding high-performance liquid chromatography, and Dr. Daniela Martins, Glória Monteiro, and Olívia Souza for laboratory and field support.
Financial support: This study was supported by grant AI030639-15S1 from the National Institutes of Health. Selma M. B. Jeronimo is a researcher of the Conselho Nacional de Desenvolvimento Científico e Tecnológico. Bruna L. Lima Maciel was supported by a fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
* Address correspondence to Selma M. B. Jerônimo, Department of Biochemistry, Federal University of Rio Grande do Norte, CP 1624, Natal, Rio Grande do Norte, 59072-970, Brazil. E-mail: smbj{at}cb.ufrn.br ![]()
Authors addresses: Bruna L. Lima Maciel, José W. Queiroz, Juliana Galvão, Núbia N. Pontes, Roberto Dimenstein, and Selma M. B. Jerônimo, Department of Biochemistry, Federal University of Rio Grande do Norte, CP 1624, Natal, Rio Grande do Norte, 59072-970, Brazil, Tel/Fax: 55-84-3215-3428, E-mail: smbj{at}cb.ufrn.br. Hênio G. Lacerda, Department of Infectious Diseases, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. Lúcia F. C. Pedrosa, Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. Stephen E. McGowan, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
| REFERENCES |
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |